Trial · NCT02759120
Adverse events58
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 58
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Arrhythmia | Cardiac disorders | Antimicrobial Therapy Plus Standard of Care | 2 | 254 | 2 |
| other | Arrhythmia | Cardiac disorders | Standard of Care | 5 | 259 | 5 |
| other | Vomiting | Gastrointestinal disorders | Antimicrobial Therapy Plus Standard of Care | 12 | 254 | 14 |
| other | Vomiting | Gastrointestinal disorders | Standard of Care | 2 | 259 | 2 |
| other | Hyperkalemia | Metabolism and nutrition disorders | Antimicrobial Therapy Plus Standard of Care | 10 | 254 | 11 |
| other | Hyperkalemia | Metabolism and nutrition disorders | Standard of Care | 2 | 259 | 2 |
| other | Rash | Skin and subcutaneous tissue disorders | Antimicrobial Therapy Plus Standard of Care | 17 | 254 | 22 |
| other | Rash | Skin and subcutaneous tissue disorders | Standard of Care | 0 | 259 | 0 |
| other | Diarrhea | Gastrointestinal disorders | Antimicrobial Therapy Plus Standard of Care | 26 | 254 | 29 |
| other | Diarrhea | Gastrointestinal disorders | Standard of Care | 8 | 259 | 8 |
| other | Other | General disorders | Antimicrobial Therapy Plus Standard of Care | 8 | 254 | 8 |
| other | Other | General disorders | Standard of Care | 7 | 259 | 7 |
| serious | Idiopathic pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | Antimicrobial Therapy Plus Standard of Care | 14 | 254 | 16 |
| serious | Idiopathic pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | Standard of Care | 5 | 259 | 6 |
| serious | Respiratory failure | Respiratory, thoracic and mediastinal disorders | Antimicrobial Therapy Plus Standard of Care | 4 | 254 | 4 |
| serious | Respiratory failure | Respiratory, thoracic and mediastinal disorders | Standard of Care | 4 | 259 | 4 |
| serious | Dyspnea | Respiratory, thoracic and mediastinal disorders | Antimicrobial Therapy Plus Standard of Care | 5 | 254 | 5 |
| serious | Dyspnea | Respiratory, thoracic and mediastinal disorders | Standard of Care | 2 | 259 | 2 |
| serious | Pulmonary embollism | Respiratory, thoracic and mediastinal disorders | Antimicrobial Therapy Plus Standard of Care | 2 | 254 | 2 |
| serious | Pulmonary embollism | Respiratory, thoracic and mediastinal disorders | Standard of Care | 3 | 259 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02759120/events